CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹5,506 Cr | ₹4,771 Cr | ₹4,057 Cr | ₹3,424 Cr | ₹3,446 Cr |
What is the latest Sundry Debtors ratio of CIPLA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹5,506 Cr |
| Mar2024 | ₹4,771 Cr |
| Mar2023 | ₹4,057 Cr |
| Mar2022 | ₹3,424 Cr |
| Mar2021 | ₹3,446 Cr |
How is Sundry Debtors of CIPLA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,506 Cr | 15.42 | |
| Mar2024 | ₹4,771 Cr | 17.59 | |
| Mar2023 | ₹4,057 Cr | 18.47 | |
| Mar2022 | ₹3,424 Cr | -0.62 | |
| Mar2021 | ₹3,446 Cr | - | |
Compare Sundry Debtors of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹99,327.1 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| MANKIND PHARMA | ₹85,816.7 Cr | 3% | -3.9% | -15.4% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 2.4% |
-7.2% |
-18.1% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses